Analyst Ratings for Five Prime Therapeutics (FPRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/9/2021 | Guggenheim | Michael Schmidt | Downgrade | Neutral (Buy) |
38.00 (N/A) |
37.76 (38.00) |
0.64% | Details |
| 3/5/2021 | Jefferies | Eun Yang | Downgrade | Hold (Buy) |
38.00 (N/A) |
21.26 (38.00) |
78.74% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


